NYSE · Healthcare
Electromed, Inc. (ELMD)
As-reported financials and recent SEC filings for Electromed, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$64.0M
Net income
$7.5M
Net margin
11.8%
Diluted EPS
$0.85
ROE
17.4%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $64.0M | $54.7M | $48.1M | $41.7M | $35.8M |
| Gross profit | $50.0M | $41.7M | $36.5M | $31.4M | $27.3M |
| Operating income | $9.7M | $6.6M | $4.0M | $3.0M | $3.1M |
| Net income | $7.5M | $5.2M | $3.2M | $2.3M | $2.4M |
| Diluted EPS | $0.85 | $0.58 | $0.36 | $0.26 | $0.27 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-02
View on EDGAR →42026-06-09
View on EDGAR →1442026-06-08
View on EDGAR →42026-06-08
View on EDGAR →1442026-06-04
View on EDGAR →SD2026-05-29
View on EDGAR →42026-05-19
View on EDGAR →1442026-05-15
View on EDGAR →Largest Healthcare peers
Go deeper on ELMD
Search Electromed, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.